VYNE Therapeutics Inc. - stock earnings
VYNE Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -6.2 million USD | 76000 USD |
2023Q3 | -6.6 million USD | 114000 USD |
2023Q2 | -10.1 million USD | 135000 USD |
2023Q1 | -5.6 million USD | 99000 USD |
2022Q4 | -7.8 million USD | 6000 USD |
2022Q3 | -9.5 million USD | 167000 USD |
2022Q2 | -8.5 million USD | 126000 USD |
2022Q1 | 4.7 million USD | 178000 USD |
2021Q4 | -11.6 million USD | 2.3 million USD |
2021Q3 | -21.3 million USD | 4.1 million USD |
2021Q2 | -19.9 million USD | 4.3 million USD |
2021Q1 | -20.6 million USD | 4.1 million USD |
2020Q4 | -23.2 million USD | 4.3 million USD |
2020Q3 | -24.7 million USD | 3.3 million USD |
2020Q2 | -167.4 million USD | 11.7 million USD |
2020Q1 | -40.2 million USD | 1.8 million USD |
2019Q4 | -21.5 million USD | ? USD |
2019Q3 | -16.9 million USD | ? USD |
2019Q2 | -16.5 million USD | ? USD |
2019Q1 | -18.9 million USD | ? USD |
2018Q4 | -17.6 million USD | -10.6 million USD |
2018Q3 | -12.8 million USD | ? USD |
2018Q2 | -8.3 million USD | 10.1 million USD |
2018Q1 | -12.7 million USD | 497000 USD |
2017Q4 | -9.3 million USD | 2.8 million USD |
2017Q3 | -8.2 million USD | 909000 USD |
2017Q2 | -6.2 million USD | 449000 USD |
2017Q1 | -5.5 million USD | 449000 USD |
2016Q4 | -4.8 million USD | 450000 USD |
VYNE Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -28.5 million USD | 424000 USD |
2022 | -33.9 million USD | 477000 USD |
2021 | -73.3 million USD | 14.8 million USD |
2020 | -255.6 million USD | 21.0 million USD |
2019 | -70.5 million USD | 1.8 million USD |
2018 | -51.4 million USD | 10.6 million USD |
2017 | -29.1 million USD | 4.6 million USD |
2016 | -14.1 million USD | 674000 USD |
2015 | -4.6 million USD | ? USD |
VYNE
Price: $2.53
52 week price:
Earnings Per Share: -2.72 USD
P/E Ratio: -0.23
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 68900
Market Capitalization: 39.1 million